Mahdieh Mehrab Mohseni
Overview
Explore the profile of Mahdieh Mehrab Mohseni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
10
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mehrab Mohseni M, Zamani H, Momeni M, Shirvani-Farsani Z
Discov Oncol
. 2024 Jun;
15(1):219.
PMID: 38856786
Zinc finger antisense 1 (ZFAS1), a newly discovered long noncoding RNA, is expressed in various tissues and organs and has been introduced an oncogenic gene in human malignancies. In various...
2.
Ghaneialvar H, Mehrab Mohseni M, Kenarkoohi A, Kakaee S
Health Sci Rep
. 2024 Jun;
7(6):e2152.
PMID: 38831779
Background: Gestational diabetes mellitus is a common public health problem, accompanied by complications for the mother and fetus. So, introducing new biomarkers to identify early diabetes is essential. As serum...
3.
Baradaran-Bagherian S, Mehrab Mohseni M, Sharifi R, Amirinejad R, Shirvani-Farsani Z
Adv Med Sci
. 2024 Apr;
69(2):231-237.
PMID: 38670228
Purpose: A lot of people are dying from pancreatic cancer (PC) annually. The early detection of this cancer is particularly challenging due to the fact that symptoms tend to appear...
4.
Naseroleslami M, Mehrab Mohseni M
Iran Biomed J
. 2024 Feb;
28(1):15-22.
PMID: 38317313
Background: Simvastatin (SIM) has anti-inflammatory and antioxidant properties against cardiac ischemia/reperfusion injury (I/RI). However, it suffers from low bioavailability and a short half-life. Nanoniosomes are novel drug delivery systems that...
5.
Ghamari M, Mehrab Mohseni M, Taheri M, Neishabouri S, Shirvani-Farsani Z
Metab Brain Dis
. 2023 Nov;
39(2):313-320.
PMID: 37962788
Long non-coding RNAs (lncRNAs) have been recently considered as one of the regulatory mechanisms of the nervous system. Hence, lncRNAs may be considered diagnostic biomarkers for bipolar disorder (BD). We...
6.
Zamani B, Mehrab Mohseni M, Naghavi Gargari B, Taheri M, Sayad A, Shirvani-Farsani Z
Sci Rep
. 2023 Aug;
13(1):13870.
PMID: 37620425
Bipolar disorder (BD) patients suffer from severe disability and premature death because of failure in prognosis, diagnosis, and treatment. Although neural mechanisms of bipolar have not been fully discovered, studies...
7.
Pirbalouti R, Mehrab Mohseni M, Taheri M, Neishabouri S, Shirvani-Farsani Z
Metab Brain Dis
. 2023 Jun;
38(7):2223-2230.
PMID: 37278925
Long non-coding RNAs (lncRNAs) are major genetic factors whose disruption lead to many diseases, including nervous system diseases. Bipolar disorder (BD) is a neuro-psychiatric disease with no definitive diagnosis and...
8.
Mehrab Mohseni M, Amani J, Fasihi Ramandi M, Mahjoubi F, Jafaria M, Salmanian A
Iran J Allergy Asthma Immunol
. 2020 Apr;
18(5):511-522.
PMID: 32245295
Human epithelial growth factor receptor2 (Her2) and polymorphic epithelial mucin (MUC1) are tumor-associated antigens that have been extensively investigated in adenocarcinomas. Generally, each of these molecules was used separately for...